Hepatitis C Virus
Genelabs Technologies, Inc. Reports Financial Results for the Second Quarter and First Half of 2007
Published in Biotech Law Weekly, August 31st, 2007
Genelabs Technologies, Inc. (NASDAQ:GNLB) reported revenues of $4.7 million and a net loss of $0.4 million, or $0.01 per share, for the second quarter of 2007. This compares to revenues of $2.3 million and a net loss of $4.3 million, or $0.24 per share, for the second quarter of 2006. Revenues for the first half of 2007 were $8.3 million, and the net loss was $0.9 million, or $0.03 per share, compared to revenues of $4.0 million and a net loss of $7.7 million, or $0.43 per share, for the first half of 2006.
At June 30, 2007, Genelabs had $23.9 million in cash and cash equivalents. At December 31, 2006, Genelabs reported cash and cash equivalents of $18.6 million.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2007-08-31)
More Articles from Biotech Law Weekly
- Acara Partners
Acara Expands to Nationwide Search for Its Medical Spa Acquisition Strategy - ADA Watch Coalition and National Coalition for Disability Rights
Senator Tom Harkin Calls for Restoration of Americans with Disabilities Act on the 'Road to Freedom' National Bus Tour - Addiction Medicine
Online Tool Educates MySpace Generation about Opioid Addiction - Amvets
AMVETS to Step Up Recruitment of Younger Veterans as it Fights for Mandatory Funding of Veterans Healthcare - Autism
Deirdre Imus, Katie Wright to Speak at '07 National Autism Conference, Atlanta - Bally Total Fitness
Bally Total Fitness Announces Noteholder Support for Proposed Amendments to Plan of Reorganization Sponsored by Harbinger Capital Partners Funds - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
